Artículos por temáticas

Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism.

Adu TS, Mabandla MV.

Metab Brain Dis. 2019 Jul 22. doi: 10.1007/s11011-019-00462-9. [Epub ahead of print]

Occupation and Parkinson disease in the Women's Health Initiative Observational Study.

Burstyn I, LaCroix AZ, Litvan I, Wallace RB, Checkoway H.

Am J Ind Med. 2019 Sep;62(9):766-776. doi: 10.1002/ajim.23022. Epub 2019 Jul 22.

SIRPα deficiency accelerates the pathologic process in models of Parkinson disease.

Wang J, Ding X, Wu X, Liu J, Zhou R, Wei P, Zhang Q, Zhang C, Zen K, Li L.

Glia. 2019 Jul 19. doi: 10.1002/glia.23689. [Epub ahead of print]

Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease.

Yoon EJ, Ismail Z, Hanganu A, Kibreab M, Hammer T, Cheetham J, Kathol I, Sarna JR, Martino D, Furtado S, Monchi O.

Neurology. 2019 Aug 20;93(8):e766-e777. doi: 10.1212/WNL.0000000000007968. Epub 2019 Jul 18.

Functional MRI Signature of Chronic Pain Relief From Deep Brain Stimulation in Parkinson Disease Patients.

DiMarzio M, Rashid T, Hancu I, Fiveland E, Prusik J, Gillogly M, Madhavan R, Joel S, Durphy J, Molho E, Hanspal E, Shin D, Pilitsis JG.

Neurosurgery. 2019 Jul 17. pii: nyz269. doi: 10.1093/neuros/nyz269. [Epub ahead of print]

New models show gut-brain transmission of Parkinson disease pathology.

Wood H.

Nat Rev Neurol. 2019 Sep;15(9):491. doi: 10.1038/s41582-019-0241-x. No abstract available.

Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity.

Baig F, Kelly MJ, Lawton MA, Ruffmann C, Rolinski M, Klein JC, Barber T, Lo C, Ben-Shlomo Y, Okai D, Hu MT.

Neurology. 2019 Aug 13;93(7):e675-e687. doi: 10.1212/WNL.0000000000007942. Epub 2019 Jul 16.

Effects of Concurrent Manual Task Performance on Connected Speech Acoustics in Individuals With Parkinson Disease.

Whitfield JA, Kriegel Z, Fullenkamp AM, Mehta DD.

J Speech Lang Hear Res. 2019 Jul 15;62(7):2099-2117. doi: 10.1044/2019_JSLHR-S-MSC18-18-0190. Epub 2019 Jul 15.

Examination of Clear Speech in Parkinson Disease Using Measures of Working Vowel Space.

Whitfield JA, Mehta DD.

J Speech Lang Hear Res. 2019 Jul 15;62(7):2082-2098. doi: 10.1044/2019_JSLHR-S-MSC18-18-0189. Epub 2019 Jul 15.

Effect of Clear Speech on the Duration of Silent Intervals at Syntactic and Phonemic Boundaries in the Speech of Individuals With Parkinson Disease.

Gravelin AC, Whitfield JA.

Am J Speech Lang Pathol. 2019 Jul 15;28(2S):793-806. doi: 10.1044/2018_AJSLP-MSC18-18-0102. Epub 2019 Jul 15.

Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations.

Modi NB, Mittur A, Dinh P, Rubens R, Gupta S.

Clin Neuropharmacol. 2019 Jul 12. doi: 10.1097/WNF.0000000000000354. [Epub ahead of print]

Vascular Parkinsonism by Infarctions at Different Locations on 18F-FP-CIT PET/CT.

Kim C, Kim DY, Hong IK.

Clin Nucl Med. 2019 Jul 12. doi: 10.1097/RLU.0000000000002721. [Epub ahead of print]

Interleaving Stimulation in Parkinson Disease: Interesting to Whom?

França C, Barbosa ER, Iglesio R, Teixeira MJ, Cury RG.

World Neurosurg. 2019 Jul 8. pii: S1878-8750(19)31880-7. doi: 10.1016/j.wneu.2019.06.223. [Epub ahead of print]

Gait analysis with wearables predicts conversion to parkinson disease.

Del Din S, Elshehabi M, Galna B, Hobert MA, Warmerdam E, Suenkel U, Brockmann K, Metzger F, Hansen C, Berg D, Rochester L, Maetzler W.

Ann Neurol. 2019 Sep;86(3):357-367. doi: 10.1002/ana.25548. Epub 2019 Jul 27.

Olfactory Identification among Various Subtypes of Parkinson Disease.

Jalali MM, Roudbary SA, Gerami H, Soleimani R, Ebrahimi SM.

Eur Neurol. 2019;81(3-4):167-173. doi: 10.1159/000501551. Epub 2019 Jul 10.